Scarica l'app Stockscreener
3.64
0.27%
-0.010
Dopo l'orario di chiusura:
3.64
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - El Paso Times
FinancialContentCONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - FinancialContent
Quantum Biopharma Ltd. Class Action Notice for Investors - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors - GlobeNewswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - Prime Publishers, Inc.
Targets Report: Will Quantum BioPharma Ltd stock benefit from M A2025 Bull vs Bear & Free Community Consensus Stock Picks - baoquankhu1.vn
Will Quantum BioPharma Ltd stock benefit from M AMarket Trend Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Quantum Biopharma Shareholders File Class Action Lawsuit - intellectia.ai
Quantum Biopharma Ltd. Class Action Alert for Investors - intellectia.ai
Quantum Biopharma Reports Q3 2025 Financial Results - MSN
QNTM Stockholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
Risk Recap: Will QNTM stock go up in YEARJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
QNTM Shareholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QNTM Investors Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum Biopharma Ltd. Faces Class Action Lawsuit Over Alleged Securities Fraud - intellectia.ai
User - FinancialContent
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Aug Mood: Should I hold or sell Quantum BioPharma Ltd now - baoquankhu1.vn
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Quantum Biopharma Ltd. to Contact the Firm Today! - accessnewswire.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Quantum Biopharma Ltd. to Contact the Firm Today! - accessnewswire.com
Aug Outlook: Will Quantum BioPharma Ltd. outperform during market ralliesVolume Spike & Low Volatility Stock Recommendations - baoquankhu1.vn
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - Chartmill
Whittier Daily News - FinancialContent
Buyback Watch: Will Quantum BioPharma Ltd. stock attract ESG investors2025 Growth vs Value & Fast Entry and Exit Trade Plans - Bộ Nội Vụ
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
Spoofing Allegations Against Banks Take Center Stage in Biotech’s Legal Fight - InvestorNews
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
About Us - FinancialContent
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in - The National Law Review
Quantum BioPharma closes private placement, enhances governance - MSN
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud LawsuitContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
Daily Breeze - FinancialContent
Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026Contact Kaplan Fox - NewMediaWire
Deadline to Lead in Securities Class Action Against Quantum Bioph - The National Law Review
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):